Stock Analiz

OptimizeRx Corp (OPRX) stock forecast and price target

Price $7.34 · data as of November 13, 2026

12-month price target

Average target$11.90
Upside / downside+62.1%
Analysts5
ConsensusStrong buy
Low $10.00Average $11.90High $18.00

Gold marker: average target · white marker: today’s price ($7.34)

Analyst ratings

Strong buy 1Buy 5Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$0.84−20.4%$89M
Next fiscal year
ends December 31, 2027
$1.05+25.8%$98M
Next quarter
ends December 31, 2026
$0.34−34.1%$27M
Quarter after
ends December 31, 2026
$0.20−61.3%$22M

Consensus of the analysts covering OptimizeRx, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.

Our model vs. Wall Street

Analysts see 62.1% upside over 12 months. Our discounted cash flow model with moderate assumptions puts OptimizeRx’s intrinsic value about 34% below today’s market value, and it scores 2.0 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the OptimizeRx stock price target?

The average 12-month target from 5 analysts is $11.90, 62.1% above the current price of $7.34 Targets range from $10.00 to $18.00.

Is OptimizeRx a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 5 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is OptimizeRx expected to earn?

Analysts expect EPS of $0.84 for the fiscal year ending December 31, 2026 and $1.05 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.